Launch of Supplement Chews
May 24 2010 - 2:00AM
UK Regulatory
TIDMONG
RNS Number : 3770M
Oxford Nutrascience Group PLC
24 May 2010
Oxford Nutrascience Group plc
("Oxford Nutrascience" or "the Company")
Validation of technology with launch of supplement chews and signing of
manufacturing agreement
Oxford Nutrascience announces the launch of two new chewy confectionery products
that use its proprietary fortified chewy confectionery system ("the
technology"). One chew is a cranberry supplement and the other is a children's
confectionery chew containing prebiotic fibre, omega-3 and vitamins A,C,D and E.
The launch of the chews provides further validation of the Company's proprietary
technology which uses soluble fibres to enable functional ingredients such as
vitamins and minerals to be added without compromising taste, texture and
stability. Importantly the technology also deliversconfectionery that is high in
fibre yet reduced in sugar and fat.
The Company has pending UK and European patent applications for the technology
and these two new products are the first applications of the Company's
technology to be brought to market.
The two products will be available to consumers during the second half of 2010
as part of the Group's own product range and are being made available to other
over-the-counter consumer healthcare companies seeking to use Oxford
Nutrascience's confectionery technology.
The launch of the chews follows the recent signing of an exclusive manufacturing
agreement with Lamy Lutti, one of the largest confectionery manufacturer's in
Europe which produces 53,000 tonnes of confectionary products a year and has a
turnover of approximately EUR130 million. The Company formally signed the
agreement with Lamy Lutti on 21 May 2010.
In addition to the two new chews announced today, Lamy Lutti is working with
Oxford Nutrascience to develop more exciting new chews using the Company's
unique proprietary technology. The partnership with Lamy Lutti provides a
scaleable production facility and also allows the Company to expand its chew
development capability. Further chews are due to be brought to market during
2011.
Nigel Theobald, Chief Executive, Oxford Nutrascience Group Plc commented:
"The launch of these two new chews is part of Oxford Nutrascience's stated
strategy of exploiting our nutraceutical and taste-masking technology by
increasing our range of vitamin chews. At last week's Vitafoods trade show in
Switzerland we had exciting levels of enquiries in our chews from both
distributors and international over-the-counter consumer healthcare companies
who are interested in working with our technology.
"Lamy Lutti have proven that they are able to manufacture our chews on a mass
scale without any detrimental affect on the nutritional benefits, taste or
chewing sensation of the final product. Our ability to attract a company of Lamy
Lutti's calibre reflects the integrity of our technology and the opportunity for
our chews."
- Ends -
For further information:
www.oxfordnutrascience.com
Oxford Nutrascience Group Plc
Nigel Theobald, Chief Executive +44 1865 854874
Mark Way, Investor and Media Relations +44 7786 116991
ZAI Corporate Finance (Nominated Adviser)
Ray Zimmerman +44 20 7060 2220
Sarang Shah +44 20 7060 2220
About Oxford Nutrascience Group Plc
· Oxford Nutrascience is a UK consumer healthcare company that develops
chewy confectionery, chewable tablets and liquid suspensions to allow medicines
and vitamin supplements to be taken in a more pleasant and convenient way.
· Oxford Nutrascience has developed technology for the use of soluble
fibres in medicine delivery systems that disperse and solubilise medicines,
improve taste and mouth feel, simplify processing and eliminate additives,
incorporate prebiotic health benefits.
· Chews: Oxford Nutrascience currently produces Ellactiva , a calcium chewy
supplement sold in the UK and in the Middle East, and plans to launch new chews
to complement this existing product.
· Chewable tablets and liquid suspensions: The target market for Oxford
Nutrasciences' Chewitabs(TM) and liquid suspension delivery systems are
over-the-counter ("OTC") pain relieving drugs, indigestion preparations and
cough and cold medicines.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCEFLFLBEFZBBX
Oxford Nutrascience (LSE:ONG)
Historical Stock Chart
From Nov 2024 to Dec 2024
Oxford Nutrascience (LSE:ONG)
Historical Stock Chart
From Dec 2023 to Dec 2024